nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—FDPS—jaw skeleton—obesity	0.0735	0.48	CbGeAlD
Ibandronate—FDPS—Cholesterol Biosynthesis—HMGCS1—obesity	0.0223	0.0682	CbGpPWpGaD
Ibandronate—FDPS—Cholesterol biosynthesis—HMGCS1—obesity	0.0164	0.0502	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—INSIG2—obesity	0.013	0.0398	CbGpPWpGaD
Ibandronate—FDPS—islet of Langerhans—obesity	0.0116	0.0759	CbGeAlD
Ibandronate—FDPS—respiratory system—obesity	0.011	0.0717	CbGeAlD
Ibandronate—FDPS—SREBP signalling—INSIG2—obesity	0.0105	0.0322	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—HMGCS1—obesity	0.0102	0.0311	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—ACACB—obesity	0.00959	0.0294	CbGpPWpGaD
Ibandronate—FDPS—adrenal cortex—obesity	0.00922	0.0602	CbGeAlD
Ibandronate—FDPS—cardiovascular system—obesity	0.00842	0.0549	CbGeAlD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—HMGCS1—obesity	0.00811	0.0248	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—GPAM—obesity	0.0077	0.0236	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—ACACB—obesity	0.00766	0.0234	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—FGF21—obesity	0.00761	0.0233	CbGpPWpGaD
Ibandronate—FDPS—pituitary gland—obesity	0.00745	0.0486	CbGeAlD
Ibandronate—FDPS—adipose tissue—obesity	0.00742	0.0484	CbGeAlD
Ibandronate—FDPS—SREBP signalling—ACLY—obesity	0.00702	0.0215	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—SREBF2—obesity	0.007	0.0214	CbGpPWpGaD
Ibandronate—FDPS—digestive system—obesity	0.00699	0.0456	CbGeAlD
Ibandronate—FDPS—adrenal gland—obesity	0.00666	0.0434	CbGeAlD
Ibandronate—FDPS—SREBP signalling—HMGCS1—obesity	0.00657	0.0201	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—SCD—obesity	0.0062	0.019	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—GPAM—obesity	0.00615	0.0188	CbGpPWpGaD
Ibandronate—FDPS—endocrine gland—obesity	0.00577	0.0377	CbGeAlD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—SREBF2—obesity	0.00559	0.0171	CbGpPWpGaD
Ibandronate—FDPS—liver—obesity	0.00521	0.034	CbGeAlD
Ibandronate—FDPS—SREBP signalling—PPARGC1B—obesity	0.00498	0.0152	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—GPAM—obesity	0.00498	0.0152	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—SREBF1—obesity	0.00482	0.0147	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—FASN—obesity	0.00458	0.014	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—SREBF2—obesity	0.00452	0.0138	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—LPIN1—obesity	0.00428	0.0131	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—NCOA1—obesity	0.00398	0.0122	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—RBP4—obesity	0.00389	0.0119	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—SREBF1—obesity	0.00385	0.0118	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—FASN—obesity	0.00366	0.0112	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—SCARB1—obesity	0.00321	0.00982	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—NCOA1—obesity	0.00318	0.00974	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—SREBF1—obesity	0.00311	0.00953	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—FASN—obesity	0.00296	0.00907	CbGpPWpGaD
Ibandronate—FDPS—Activation of gene expression by SREBF (SREBP)—PPARA—obesity	0.00289	0.00886	CbGpPWpGaD
Ibandronate—FDPS—Regulation of cholesterol biosynthesis by SREBP (SREBF)—PPARA—obesity	0.00231	0.00707	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—SIRT1—obesity	0.00225	0.00689	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—LPL—obesity	0.00212	0.00648	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPM1L—obesity	0.00195	0.00596	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—INSIG2—obesity	0.00195	0.00596	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—INPP5E—obesity	0.00178	0.00545	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ME1—obesity	0.00165	0.00506	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PNPLA3—obesity	0.00156	0.00476	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—PPARG—obesity	0.00155	0.00473	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—INS—obesity	0.00152	0.00464	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—DGAT2—obesity	0.00147	0.00451	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LIPE—obesity	0.00141	0.00431	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—MUT—obesity	0.00141	0.00431	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—DGAT1—obesity	0.00135	0.00413	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ACLY—obesity	0.0013	0.00397	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ALOX12—obesity	0.00125	0.00384	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—MTOR—obesity	0.00123	0.00376	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HMGCS1—obesity	0.00121	0.00372	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PLIN1—obesity	0.00118	0.00361	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PNPLA2—obesity	0.00118	0.00361	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ANGPTL4—obesity	0.00118	0.00361	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ACADM—obesity	0.00118	0.00361	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ACACB—obesity	0.00115	0.00351	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—OXCT1—obesity	0.00115	0.00351	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CA3—obesity	0.00114	0.0035	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PNLIP—obesity	0.00112	0.00342	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SRD5A1—obesity	0.00112	0.00342	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—STS—obesity	0.00107	0.00326	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARD—obesity	0.00104	0.00319	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SLC27A1—obesity	0.00102	0.00313	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—FABP4—obesity	0.001	0.00307	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GLRX—obesity	0.000972	0.00298	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ECHS1—obesity	0.00095	0.00291	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HSD11B1—obesity	0.00095	0.00291	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARGC1B—obesity	0.00092	0.00282	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ACSL1—obesity	0.00092	0.00282	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—GPAM—obesity	0.00092	0.00282	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—HADH—obesity	0.000894	0.00274	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—FADS1—obesity	0.000894	0.00274	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPM1L—obesity	0.000867	0.00265	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—OTC—obesity	0.000867	0.00265	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ETFDH—obesity	0.000867	0.00265	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—INSIG2—obesity	0.000867	0.00265	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SREBF2—obesity	0.000837	0.00256	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LPA—obesity	0.000808	0.00247	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GPT—obesity	0.000793	0.00243	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—INPP5E—obesity	0.000793	0.00243	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—UQCRC2—obesity	0.000793	0.00243	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LPIN1—obesity	0.000791	0.00242	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOA5—obesity	0.000775	0.00237	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—PIK3CA—obesity	0.000749	0.00229	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CLOCK—obesity	0.000739	0.00226	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ALDH6A1—obesity	0.000737	0.00226	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SUCLG2—obesity	0.000737	0.00226	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ME1—obesity	0.000737	0.00226	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SULT2A1—obesity	0.00072	0.0022	CbGpPWpGaD
Ibandronate—Rash—Diethylpropion—obesity	0.000697	0.00134	CcSEcCtD
Ibandronate—Dysgeusia—Orlistat—obesity	0.000697	0.00134	CcSEcCtD
Ibandronate—Dermatitis—Diethylpropion—obesity	0.000696	0.00134	CcSEcCtD
Ibandronate—Dizziness—Cimetidine—obesity	0.000695	0.00134	CcSEcCtD
Ibandronate—Haemoglobin—Bupropion—obesity	0.000693	0.00133	CcSEcCtD
Ibandronate—FDPS—Metabolism—PNPLA3—obesity	0.000693	0.00212	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—COX7C—obesity	0.000693	0.00212	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—UCP1—obesity	0.000693	0.00212	CbGpPWpGaD
Ibandronate—Headache—Diethylpropion—obesity	0.000692	0.00133	CcSEcCtD
Ibandronate—Haemorrhage—Bupropion—obesity	0.00069	0.00133	CcSEcCtD
Ibandronate—Malnutrition—Sibutramine—obesity	0.000688	0.00132	CcSEcCtD
Ibandronate—Back pain—Orlistat—obesity	0.000688	0.00132	CcSEcCtD
Ibandronate—Pharyngitis—Bupropion—obesity	0.000684	0.00132	CcSEcCtD
Ibandronate—Muscle spasms—Orlistat—obesity	0.000684	0.00132	CcSEcCtD
Ibandronate—Urinary tract disorder—Bupropion—obesity	0.000681	0.00131	CcSEcCtD
Ibandronate—Oedema peripheral—Bupropion—obesity	0.000679	0.00131	CcSEcCtD
Ibandronate—Flatulence—Sibutramine—obesity	0.000678	0.0013	CcSEcCtD
Ibandronate—Connective tissue disorder—Bupropion—obesity	0.000678	0.0013	CcSEcCtD
Ibandronate—Urethral disorder—Bupropion—obesity	0.000676	0.0013	CcSEcCtD
Ibandronate—Amnesia—Topiramate—obesity	0.000676	0.0013	CcSEcCtD
Ibandronate—Dysgeusia—Sibutramine—obesity	0.000674	0.0013	CcSEcCtD
Ibandronate—Vomiting—Cimetidine—obesity	0.000669	0.00129	CcSEcCtD
Ibandronate—Thirst—Topiramate—obesity	0.000667	0.00128	CcSEcCtD
Ibandronate—Back pain—Sibutramine—obesity	0.000666	0.00128	CcSEcCtD
Ibandronate—Rash—Cimetidine—obesity	0.000663	0.00128	CcSEcCtD
Ibandronate—Dermatitis—Cimetidine—obesity	0.000662	0.00127	CcSEcCtD
Ibandronate—Muscle spasms—Sibutramine—obesity	0.000662	0.00127	CcSEcCtD
Ibandronate—Ill-defined disorder—Orlistat—obesity	0.00066	0.00127	CcSEcCtD
Ibandronate—Headache—Cimetidine—obesity	0.000659	0.00127	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CPT1A—obesity	0.000659	0.00202	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—DGAT2—obesity	0.000657	0.00201	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CS—obesity	0.000657	0.00201	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CPS1—obesity	0.000657	0.00201	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SUCLA2—obesity	0.000657	0.00201	CbGpPWpGaD
Ibandronate—Nausea—Diethylpropion—obesity	0.000657	0.00126	CcSEcCtD
Ibandronate—Angioedema—Orlistat—obesity	0.00065	0.00125	CcSEcCtD
Ibandronate—Eye disorder—Bupropion—obesity	0.000644	0.00124	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LIPC—obesity	0.000642	0.00197	CbGpPWpGaD
Ibandronate—Malaise—Orlistat—obesity	0.000642	0.00123	CcSEcCtD
Ibandronate—Cardiac disorder—Bupropion—obesity	0.00064	0.00123	CcSEcCtD
Ibandronate—Vertigo—Orlistat—obesity	0.000639	0.00123	CcSEcCtD
Ibandronate—Ill-defined disorder—Sibutramine—obesity	0.000639	0.00123	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOC3—obesity	0.000638	0.00195	CbGpPWpGaD
Ibandronate—Anaemia—Sibutramine—obesity	0.000636	0.00122	CcSEcCtD
Ibandronate—Pain in extremity—Topiramate—obesity	0.000635	0.00122	CcSEcCtD
Ibandronate—Osteoarthritis—Topiramate—obesity	0.000635	0.00122	CcSEcCtD
Ibandronate—Angioedema—Sibutramine—obesity	0.000629	0.00121	CcSEcCtD
Ibandronate—Palpitations—Orlistat—obesity	0.000629	0.00121	CcSEcCtD
Ibandronate—FDPS—Metabolism—LIPE—obesity	0.000627	0.00192	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—MUT—obesity	0.000627	0.00192	CbGpPWpGaD
Ibandronate—Angiopathy—Bupropion—obesity	0.000626	0.0012	CcSEcCtD
Ibandronate—Migraine—Topiramate—obesity	0.000625	0.0012	CcSEcCtD
Ibandronate—Nausea—Cimetidine—obesity	0.000625	0.0012	CcSEcCtD
Ibandronate—Immune system disorder—Bupropion—obesity	0.000623	0.0012	CcSEcCtD
Ibandronate—Mediastinal disorder—Bupropion—obesity	0.000621	0.00119	CcSEcCtD
Ibandronate—Malaise—Sibutramine—obesity	0.000621	0.00119	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CETP—obesity	0.000619	0.0019	CbGpPWpGaD
Ibandronate—Chills—Bupropion—obesity	0.000619	0.00119	CcSEcCtD
Ibandronate—Vertigo—Sibutramine—obesity	0.000619	0.00119	CcSEcCtD
Ibandronate—Face oedema—Topiramate—obesity	0.000613	0.00118	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SDC1—obesity	0.000612	0.00187	CbGpPWpGaD
Ibandronate—FDPS—SREBP signalling—AKT1—obesity	0.000612	0.00187	CbGpPWpGaD
Ibandronate—Alopecia—Bupropion—obesity	0.000609	0.00117	CcSEcCtD
Ibandronate—Palpitations—Sibutramine—obesity	0.000608	0.00117	CcSEcCtD
Ibandronate—Myalgia—Orlistat—obesity	0.000606	0.00116	CcSEcCtD
Ibandronate—Chest pain—Orlistat—obesity	0.000606	0.00116	CcSEcCtD
Ibandronate—Mental disorder—Bupropion—obesity	0.000604	0.00116	CcSEcCtD
Ibandronate—Urinary retention—Topiramate—obesity	0.000604	0.00116	CcSEcCtD
Ibandronate—Anxiety—Orlistat—obesity	0.000604	0.00116	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—AKR1C3—obesity	0.000602	0.00184	CbGpPWpGaD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000601	0.00116	CcSEcCtD
Ibandronate—FDPS—Metabolism—DGAT1—obesity	0.000601	0.00184	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYB5A—obesity	0.000601	0.00184	CbGpPWpGaD
Ibandronate—Malnutrition—Bupropion—obesity	0.0006	0.00115	CcSEcCtD
Ibandronate—Discomfort—Orlistat—obesity	0.000598	0.00115	CcSEcCtD
Ibandronate—Blood creatinine increased—Topiramate—obesity	0.000595	0.00114	CcSEcCtD
Ibandronate—Hypertension—Sibutramine—obesity	0.000594	0.00114	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SCARB1—obesity	0.000593	0.00182	CbGpPWpGaD
Ibandronate—Dry mouth—Orlistat—obesity	0.000592	0.00114	CcSEcCtD
Ibandronate—Flatulence—Bupropion—obesity	0.000591	0.00114	CcSEcCtD
Ibandronate—Dysgeusia—Bupropion—obesity	0.000588	0.00113	CcSEcCtD
Ibandronate—Chest pain—Sibutramine—obesity	0.000586	0.00113	CcSEcCtD
Ibandronate—Myalgia—Sibutramine—obesity	0.000586	0.00113	CcSEcCtD
Ibandronate—Arthralgia—Sibutramine—obesity	0.000586	0.00113	CcSEcCtD
Ibandronate—Anxiety—Sibutramine—obesity	0.000584	0.00112	CcSEcCtD
Ibandronate—Anaphylactic shock—Orlistat—obesity	0.000581	0.00112	CcSEcCtD
Ibandronate—Back pain—Bupropion—obesity	0.000581	0.00112	CcSEcCtD
Ibandronate—Abdominal pain upper—Topiramate—obesity	0.00058	0.00112	CcSEcCtD
Ibandronate—Discomfort—Sibutramine—obesity	0.000579	0.00111	CcSEcCtD
Ibandronate—FDPS—Metabolism—ACLY—obesity	0.000578	0.00177	CbGpPWpGaD
Ibandronate—Muscle spasms—Bupropion—obesity	0.000577	0.00111	CcSEcCtD
Ibandronate—Infection—Orlistat—obesity	0.000577	0.00111	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—SREBF1—obesity	0.000576	0.00176	CbGpPWpGaD
Ibandronate—Breast disorder—Topiramate—obesity	0.000574	0.0011	CcSEcCtD
Ibandronate—Dry mouth—Sibutramine—obesity	0.000573	0.0011	CcSEcCtD
Ibandronate—Nervous system disorder—Orlistat—obesity	0.000569	0.00109	CcSEcCtD
Ibandronate—Nasopharyngitis—Topiramate—obesity	0.000568	0.00109	CcSEcCtD
Ibandronate—Skin disorder—Orlistat—obesity	0.000564	0.00108	CcSEcCtD
Ibandronate—Gastritis—Topiramate—obesity	0.000562	0.00108	CcSEcCtD
Ibandronate—Anaphylactic shock—Sibutramine—obesity	0.000562	0.00108	CcSEcCtD
Ibandronate—Hyperhidrosis—Orlistat—obesity	0.000561	0.00108	CcSEcCtD
Ibandronate—FDPS—Metabolism—ALOX12—obesity	0.000558	0.00171	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ENPP1—obesity	0.000558	0.00171	CbGpPWpGaD
Ibandronate—Infection—Sibutramine—obesity	0.000558	0.00107	CcSEcCtD
Ibandronate—Ill-defined disorder—Bupropion—obesity	0.000557	0.00107	CcSEcCtD
Ibandronate—Anaemia—Bupropion—obesity	0.000555	0.00107	CcSEcCtD
Ibandronate—Shock—Sibutramine—obesity	0.000553	0.00106	CcSEcCtD
Ibandronate—Asthma—Topiramate—obesity	0.000549	0.00106	CcSEcCtD
Ibandronate—Dysphagia—Topiramate—obesity	0.000549	0.00106	CcSEcCtD
Ibandronate—Angioedema—Bupropion—obesity	0.000548	0.00105	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—FASN—obesity	0.000548	0.00168	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—BCHE—obesity	0.000546	0.00167	CbGpPWpGaD
Ibandronate—Skin disorder—Sibutramine—obesity	0.000546	0.00105	CcSEcCtD
Ibandronate—Hyperhidrosis—Sibutramine—obesity	0.000543	0.00104	CcSEcCtD
Ibandronate—Malaise—Bupropion—obesity	0.000541	0.00104	CcSEcCtD
Ibandronate—FDPS—Metabolism—HMGCS1—obesity	0.000541	0.00166	CbGpPWpGaD
Ibandronate—Vertigo—Bupropion—obesity	0.000539	0.00104	CcSEcCtD
Ibandronate—Palpitations—Bupropion—obesity	0.00053	0.00102	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Orlistat—obesity	0.000529	0.00102	CcSEcCtD
Ibandronate—Bronchitis—Topiramate—obesity	0.000528	0.00101	CcSEcCtD
Ibandronate—Abdominal discomfort—Topiramate—obesity	0.000526	0.00101	CcSEcCtD
Ibandronate—Insomnia—Orlistat—obesity	0.000525	0.00101	CcSEcCtD
Ibandronate—FDPS—Metabolism—ANGPTL4—obesity	0.000525	0.00161	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ACADM—obesity	0.000525	0.00161	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PFKFB3—obesity	0.000525	0.00161	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PNPLA2—obesity	0.000525	0.00161	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SAT1—obesity	0.000525	0.00161	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PLIN1—obesity	0.000525	0.00161	CbGpPWpGaD
Ibandronate—Paraesthesia—Orlistat—obesity	0.000521	0.001	CcSEcCtD
Ibandronate—Hypertension—Bupropion—obesity	0.000518	0.000997	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Sibutramine—obesity	0.000512	0.000984	CcSEcCtD
Ibandronate—Dyspepsia—Orlistat—obesity	0.000511	0.000983	CcSEcCtD
Ibandronate—Arthralgia—Bupropion—obesity	0.000511	0.000983	CcSEcCtD
Ibandronate—Chest pain—Bupropion—obesity	0.000511	0.000983	CcSEcCtD
Ibandronate—Myalgia—Bupropion—obesity	0.000511	0.000983	CcSEcCtD
Ibandronate—FDPS—Metabolism—OXCT1—obesity	0.000511	0.00156	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ACACB—obesity	0.000511	0.00156	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYTB—obesity	0.000511	0.00156	CbGpPWpGaD
Ibandronate—Upper respiratory tract infection—Topiramate—obesity	0.00051	0.000981	CcSEcCtD
Ibandronate—Anxiety—Bupropion—obesity	0.000509	0.000979	CcSEcCtD
Ibandronate—Insomnia—Sibutramine—obesity	0.000508	0.000977	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000507	0.000976	CcSEcCtD
Ibandronate—Discomfort—Bupropion—obesity	0.000505	0.000971	CcSEcCtD
Ibandronate—Decreased appetite—Orlistat—obesity	0.000505	0.000971	CcSEcCtD
Ibandronate—Paraesthesia—Sibutramine—obesity	0.000505	0.00097	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Orlistat—obesity	0.000501	0.000964	CcSEcCtD
Ibandronate—Fatigue—Orlistat—obesity	0.000501	0.000963	CcSEcCtD
Ibandronate—Dry mouth—Bupropion—obesity	0.0005	0.000961	CcSEcCtD
Ibandronate—FDPS—Metabolism—PNLIP—obesity	0.000498	0.00152	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SRD5A1—obesity	0.000498	0.00152	CbGpPWpGaD
Ibandronate—Weight decreased—Topiramate—obesity	0.000497	0.000955	CcSEcCtD
Ibandronate—Pain—Orlistat—obesity	0.000497	0.000955	CcSEcCtD
Ibandronate—Dyspepsia—Sibutramine—obesity	0.000495	0.000951	CcSEcCtD
Ibandronate—Pneumonia—Topiramate—obesity	0.000492	0.000946	CcSEcCtD
Ibandronate—Anaphylactic shock—Bupropion—obesity	0.00049	0.000942	CcSEcCtD
Ibandronate—Infestation—Topiramate—obesity	0.000489	0.000941	CcSEcCtD
Ibandronate—Infestation NOS—Topiramate—obesity	0.000489	0.000941	CcSEcCtD
Ibandronate—Decreased appetite—Sibutramine—obesity	0.000488	0.000939	CcSEcCtD
Ibandronate—Depression—Topiramate—obesity	0.000488	0.000938	CcSEcCtD
Ibandronate—Infection—Bupropion—obesity	0.000487	0.000936	CcSEcCtD
Ibandronate—FDPS—Metabolism—SDC3—obesity	0.000486	0.00149	CbGpPWpGaD
Ibandronate—Gastrointestinal disorder—Sibutramine—obesity	0.000485	0.000933	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—GGT1—obesity	0.000484	0.00148	CbGpPWpGaD
Ibandronate—Shock—Bupropion—obesity	0.000482	0.000927	CcSEcCtD
Ibandronate—Renal failure—Topiramate—obesity	0.000481	0.000925	CcSEcCtD
Ibandronate—Pain—Sibutramine—obesity	0.000481	0.000924	CcSEcCtD
Ibandronate—Constipation—Sibutramine—obesity	0.000481	0.000924	CcSEcCtD
Ibandronate—Nervous system disorder—Bupropion—obesity	0.00048	0.000924	CcSEcCtD
Ibandronate—Feeling abnormal—Orlistat—obesity	0.000478	0.00092	CcSEcCtD
Ibandronate—Stomatitis—Topiramate—obesity	0.000477	0.000917	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—NCOA1—obesity	0.000476	0.00146	CbGpPWpGaD
Ibandronate—Skin disorder—Bupropion—obesity	0.000476	0.000915	CcSEcCtD
Ibandronate—Urinary tract infection—Topiramate—obesity	0.000476	0.000915	CcSEcCtD
Ibandronate—FDPS—Metabolism—HK2—obesity	0.000475	0.00145	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP26B1—obesity	0.000475	0.00145	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—STS—obesity	0.000475	0.00145	CbGpPWpGaD
Ibandronate—Gastrointestinal pain—Orlistat—obesity	0.000475	0.000913	CcSEcCtD
Ibandronate—Hyperhidrosis—Bupropion—obesity	0.000474	0.000911	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CYP19A1—obesity	0.000469	0.00144	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPARD—obesity	0.000465	0.00142	CbGpPWpGaD
Ibandronate—Feeling abnormal—Sibutramine—obesity	0.000463	0.00089	CcSEcCtD
Ibandronate—Urticaria—Orlistat—obesity	0.000461	0.000887	CcSEcCtD
Ibandronate—Gastrointestinal pain—Sibutramine—obesity	0.000459	0.000884	CcSEcCtD
Ibandronate—Abdominal pain—Orlistat—obesity	0.000459	0.000883	CcSEcCtD
Ibandronate—Body temperature increased—Orlistat—obesity	0.000459	0.000883	CcSEcCtD
Ibandronate—FDPS—Metabolism—SLC27A1—obesity	0.000455	0.00139	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GLUL—obesity	0.000446	0.00137	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—FABP4—obesity	0.000446	0.00137	CbGpPWpGaD
Ibandronate—Urticaria—Sibutramine—obesity	0.000446	0.000858	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Bupropion—obesity	0.000446	0.000858	CcSEcCtD
Ibandronate—Abdominal pain—Sibutramine—obesity	0.000444	0.000854	CcSEcCtD
Ibandronate—Body temperature increased—Sibutramine—obesity	0.000444	0.000854	CcSEcCtD
Ibandronate—Insomnia—Bupropion—obesity	0.000443	0.000852	CcSEcCtD
Ibandronate—Haemoglobin—Topiramate—obesity	0.000442	0.000849	CcSEcCtD
Ibandronate—Paraesthesia—Bupropion—obesity	0.00044	0.000846	CcSEcCtD
Ibandronate—Haemorrhage—Topiramate—obesity	0.000439	0.000845	CcSEcCtD
Ibandronate—Pharyngitis—Topiramate—obesity	0.000436	0.000838	CcSEcCtD
Ibandronate—Urinary tract disorder—Topiramate—obesity	0.000434	0.000834	CcSEcCtD
Ibandronate—Oedema peripheral—Topiramate—obesity	0.000433	0.000832	CcSEcCtD
Ibandronate—Connective tissue disorder—Topiramate—obesity	0.000432	0.00083	CcSEcCtD
Ibandronate—Dyspepsia—Bupropion—obesity	0.000431	0.000829	CcSEcCtD
Ibandronate—Urethral disorder—Topiramate—obesity	0.000431	0.000828	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARGC1A—obesity	0.00043	0.00132	CbGpPWpGaD
Ibandronate—Hypersensitivity—Orlistat—obesity	0.000428	0.000823	CcSEcCtD
Ibandronate—Decreased appetite—Bupropion—obesity	0.000426	0.000819	CcSEcCtD
Ibandronate—FDPS—Metabolism—UCP3—obesity	0.000423	0.0013	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HSD11B1—obesity	0.000423	0.0013	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—UCP2—obesity	0.000423	0.0013	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ECHS1—obesity	0.000423	0.0013	CbGpPWpGaD
Ibandronate—Gastrointestinal disorder—Bupropion—obesity	0.000423	0.000813	CcSEcCtD
Ibandronate—Fatigue—Bupropion—obesity	0.000422	0.000812	CcSEcCtD
Ibandronate—Pain—Bupropion—obesity	0.000419	0.000806	CcSEcCtD
Ibandronate—Constipation—Bupropion—obesity	0.000419	0.000806	CcSEcCtD
Ibandronate—Asthenia—Orlistat—obesity	0.000417	0.000801	CcSEcCtD
Ibandronate—FDPS—Metabolism—ADH1B—obesity	0.000416	0.00127	CbGpPWpGaD
Ibandronate—Hypersensitivity—Sibutramine—obesity	0.000414	0.000796	CcSEcCtD
Ibandronate—Pruritus—Orlistat—obesity	0.000411	0.00079	CcSEcCtD
Ibandronate—Eye disorder—Topiramate—obesity	0.000411	0.000789	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOB—obesity	0.00041	0.00126	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GPAM—obesity	0.00041	0.00125	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPARGC1B—obesity	0.00041	0.00125	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ACSL1—obesity	0.00041	0.00125	CbGpPWpGaD
Ibandronate—Cardiac disorder—Topiramate—obesity	0.000408	0.000784	CcSEcCtD
Ibandronate—Feeling abnormal—Bupropion—obesity	0.000404	0.000776	CcSEcCtD
Ibandronate—Asthenia—Sibutramine—obesity	0.000403	0.000775	CcSEcCtD
Ibandronate—Gastrointestinal pain—Bupropion—obesity	0.000401	0.00077	CcSEcCtD
Ibandronate—Angiopathy—Topiramate—obesity	0.000399	0.000766	CcSEcCtD
Ibandronate—FDPS—Metabolism—HADH—obesity	0.000398	0.00122	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PCK1—obesity	0.000398	0.00122	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—FADS1—obesity	0.000398	0.00122	CbGpPWpGaD
Ibandronate—Pruritus—Sibutramine—obesity	0.000398	0.000764	CcSEcCtD
Ibandronate—Diarrhoea—Orlistat—obesity	0.000397	0.000764	CcSEcCtD
Ibandronate—Immune system disorder—Topiramate—obesity	0.000397	0.000763	CcSEcCtD
Ibandronate—Mediastinal disorder—Topiramate—obesity	0.000396	0.000761	CcSEcCtD
Ibandronate—Chills—Topiramate—obesity	0.000394	0.000758	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—LPL—obesity	0.000392	0.0012	CbGpPWpGaD
Ibandronate—Urticaria—Bupropion—obesity	0.000389	0.000748	CcSEcCtD
Ibandronate—Alopecia—Topiramate—obesity	0.000388	0.000746	CcSEcCtD
Ibandronate—Abdominal pain—Bupropion—obesity	0.000387	0.000745	CcSEcCtD
Ibandronate—Body temperature increased—Bupropion—obesity	0.000387	0.000745	CcSEcCtD
Ibandronate—FDPS—Metabolism—ACP5—obesity	0.000387	0.00118	CbGpPWpGaD
Ibandronate—Mental disorder—Topiramate—obesity	0.000385	0.00074	CcSEcCtD
Ibandronate—Diarrhoea—Sibutramine—obesity	0.000384	0.000739	CcSEcCtD
Ibandronate—Dizziness—Orlistat—obesity	0.000384	0.000738	CcSEcCtD
Ibandronate—Erythema—Topiramate—obesity	0.000382	0.000735	CcSEcCtD
Ibandronate—Malnutrition—Topiramate—obesity	0.000382	0.000735	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—obesity	0.000382	0.00117	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—G6PD—obesity	0.000377	0.00115	CbGpPWpGaD
Ibandronate—Flatulence—Topiramate—obesity	0.000377	0.000725	CcSEcCtD
Ibandronate—Dysgeusia—Topiramate—obesity	0.000374	0.00072	CcSEcCtD
Ibandronate—FDPS—Metabolism—HK1—obesity	0.000373	0.00114	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SREBF2—obesity	0.000373	0.00114	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CD36—obesity	0.000372	0.00114	CbGpPWpGaD
Ibandronate—Dizziness—Sibutramine—obesity	0.000372	0.000715	CcSEcCtD
Ibandronate—Back pain—Topiramate—obesity	0.00037	0.000711	CcSEcCtD
Ibandronate—Vomiting—Orlistat—obesity	0.000369	0.00071	CcSEcCtD
Ibandronate—Muscle spasms—Topiramate—obesity	0.000368	0.000707	CcSEcCtD
Ibandronate—Rash—Orlistat—obesity	0.000366	0.000704	CcSEcCtD
Ibandronate—Dermatitis—Orlistat—obesity	0.000366	0.000703	CcSEcCtD
Ibandronate—Headache—Orlistat—obesity	0.000364	0.000699	CcSEcCtD
Ibandronate—Hypersensitivity—Bupropion—obesity	0.000361	0.000694	CcSEcCtD
Ibandronate—FDPS—Metabolism—LPA—obesity	0.00036	0.0011	CbGpPWpGaD
Ibandronate—Vomiting—Sibutramine—obesity	0.000357	0.000687	CcSEcCtD
Ibandronate—Ill-defined disorder—Topiramate—obesity	0.000355	0.000682	CcSEcCtD
Ibandronate—Rash—Sibutramine—obesity	0.000354	0.000681	CcSEcCtD
Ibandronate—Dermatitis—Sibutramine—obesity	0.000354	0.000681	CcSEcCtD
Ibandronate—Anaemia—Topiramate—obesity	0.000353	0.00068	CcSEcCtD
Ibandronate—FDPS—Metabolism—LPIN1—obesity	0.000352	0.00108	CbGpPWpGaD
Ibandronate—Headache—Sibutramine—obesity	0.000352	0.000677	CcSEcCtD
Ibandronate—Asthenia—Bupropion—obesity	0.000351	0.000676	CcSEcCtD
Ibandronate—Pruritus—Bupropion—obesity	0.000347	0.000666	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARA—obesity	0.000346	0.00106	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—APOA5—obesity	0.000345	0.00106	CbGpPWpGaD
Ibandronate—Nausea—Orlistat—obesity	0.000345	0.000663	CcSEcCtD
Ibandronate—Malaise—Topiramate—obesity	0.000345	0.000663	CcSEcCtD
Ibandronate—Vertigo—Topiramate—obesity	0.000344	0.000661	CcSEcCtD
Ibandronate—Palpitations—Topiramate—obesity	0.000338	0.00065	CcSEcCtD
Ibandronate—Diarrhoea—Bupropion—obesity	0.000335	0.000645	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—AGT—obesity	0.000335	0.00103	CbGpPWpGaD
Ibandronate—Nausea—Sibutramine—obesity	0.000334	0.000642	CcSEcCtD
Ibandronate—Hypertension—Topiramate—obesity	0.00033	0.000635	CcSEcCtD
Ibandronate—FDPS—Metabolism—SLC22A1—obesity	0.000329	0.00101	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CLOCK—obesity	0.000329	0.00101	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOE—obesity	0.000328	0.00101	CbGpPWpGaD
Ibandronate—Myalgia—Topiramate—obesity	0.000326	0.000626	CcSEcCtD
Ibandronate—Arthralgia—Topiramate—obesity	0.000326	0.000626	CcSEcCtD
Ibandronate—Chest pain—Topiramate—obesity	0.000326	0.000626	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—obesity	0.000325	0.000996	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—obesity	0.000325	0.000994	CbGpPWpGaD
Ibandronate—Anxiety—Topiramate—obesity	0.000324	0.000624	CcSEcCtD
Ibandronate—Dizziness—Bupropion—obesity	0.000324	0.000623	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000323	0.000622	CcSEcCtD
Ibandronate—Discomfort—Topiramate—obesity	0.000322	0.000619	CcSEcCtD
Ibandronate—FDPS—Metabolism—SULT2A1—obesity	0.000321	0.000982	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GLP1R—obesity	0.000321	0.000982	CbGpPWpGaD
Ibandronate—Dry mouth—Topiramate—obesity	0.000318	0.000612	CcSEcCtD
Ibandronate—FDPS—Metabolism—DPYD—obesity	0.000316	0.000966	CbGpPWpGaD
Ibandronate—Vomiting—Bupropion—obesity	0.000311	0.000599	CcSEcCtD
Ibandronate—Infection—Topiramate—obesity	0.00031	0.000596	CcSEcCtD
Ibandronate—Rash—Bupropion—obesity	0.000309	0.000594	CcSEcCtD
Ibandronate—Dermatitis—Bupropion—obesity	0.000309	0.000593	CcSEcCtD
Ibandronate—Shock—Topiramate—obesity	0.000307	0.00059	CcSEcCtD
Ibandronate—Headache—Bupropion—obesity	0.000307	0.00059	CcSEcCtD
Ibandronate—Nervous system disorder—Topiramate—obesity	0.000306	0.000589	CcSEcCtD
Ibandronate—FDPS—Metabolism—PRKAR2B—obesity	0.000304	0.00093	CbGpPWpGaD
Ibandronate—Skin disorder—Topiramate—obesity	0.000303	0.000583	CcSEcCtD
Ibandronate—Hyperhidrosis—Topiramate—obesity	0.000302	0.00058	CcSEcCtD
Ibandronate—FDPS—Metabolism—DCN—obesity	0.000302	0.000923	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—obesity	0.000296	0.000907	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CPT1A—obesity	0.000293	0.000898	CbGpPWpGaD
Ibandronate—Nausea—Bupropion—obesity	0.000291	0.00056	CcSEcCtD
Ibandronate—FDPS—Metabolism—NAMPT—obesity	0.000288	0.000881	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—obesity	0.000286	0.000876	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GCK—obesity	0.000286	0.000875	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—LIPC—obesity	0.000286	0.000875	CbGpPWpGaD
Ibandronate—Musculoskeletal discomfort—Topiramate—obesity	0.000284	0.000547	CcSEcCtD
Ibandronate—FDPS—Metabolism—APOC3—obesity	0.000284	0.00087	CbGpPWpGaD
Ibandronate—Insomnia—Topiramate—obesity	0.000282	0.000543	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—POMC—obesity	0.000282	0.000863	CbGpPWpGaD
Ibandronate—Paraesthesia—Topiramate—obesity	0.00028	0.000539	CcSEcCtD
Ibandronate—FDPS—Metabolism—CETP—obesity	0.000276	0.000844	CbGpPWpGaD
Ibandronate—Dyspepsia—Topiramate—obesity	0.000275	0.000528	CcSEcCtD
Ibandronate—FDPS—Metabolism—SDC1—obesity	0.000273	0.000835	CbGpPWpGaD
Ibandronate—Decreased appetite—Topiramate—obesity	0.000271	0.000522	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Topiramate—obesity	0.000269	0.000518	CcSEcCtD
Ibandronate—Fatigue—Topiramate—obesity	0.000269	0.000517	CcSEcCtD
Ibandronate—FDPS—Metabolism—AKR1C3—obesity	0.000268	0.000821	CbGpPWpGaD
Ibandronate—Pain—Topiramate—obesity	0.000267	0.000513	CcSEcCtD
Ibandronate—Constipation—Topiramate—obesity	0.000267	0.000513	CcSEcCtD
Ibandronate—FDPS—Metabolism—SCARB1—obesity	0.000264	0.000809	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—obesity	0.000261	0.000797	CbGpPWpGaD
Ibandronate—Feeling abnormal—Topiramate—obesity	0.000257	0.000495	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—ALB—obesity	0.000257	0.000787	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SREBF1—obesity	0.000256	0.000785	CbGpPWpGaD
Ibandronate—Gastrointestinal pain—Topiramate—obesity	0.000255	0.000491	CcSEcCtD
Ibandronate—FDPS—Metabolism—GOT2—obesity	0.000249	0.000764	CbGpPWpGaD
Ibandronate—Urticaria—Topiramate—obesity	0.000248	0.000477	CcSEcCtD
Ibandronate—Body temperature increased—Topiramate—obesity	0.000247	0.000474	CcSEcCtD
Ibandronate—Abdominal pain—Topiramate—obesity	0.000247	0.000474	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PIK3R1—obesity	0.000246	0.000753	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—FASN—obesity	0.000244	0.000747	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—BCHE—obesity	0.000243	0.000744	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP2E1—obesity	0.000235	0.000718	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NQO1—obesity	0.000232	0.00071	CbGpPWpGaD
Ibandronate—Hypersensitivity—Topiramate—obesity	0.00023	0.000442	CcSEcCtD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—obesity	0.000227	0.000695	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—obesity	0.000225	0.000689	CbGpPWpGaD
Ibandronate—Asthenia—Topiramate—obesity	0.000224	0.000431	CcSEcCtD
Ibandronate—FDPS—Metabolism—GCG—obesity	0.000222	0.000681	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—SLC2A4—obesity	0.000222	0.000681	CbGpPWpGaD
Ibandronate—Pruritus—Topiramate—obesity	0.000221	0.000425	CcSEcCtD
Ibandronate—FDPS—Metabolism—CYCS—obesity	0.000219	0.000672	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GOT1—obesity	0.000215	0.000659	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GGT1—obesity	0.000215	0.000659	CbGpPWpGaD
Ibandronate—Diarrhoea—Topiramate—obesity	0.000214	0.000411	CcSEcCtD
Ibandronate—FDPS—Metabolism—NCOA1—obesity	0.000212	0.000649	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—STK11—obesity	0.000209	0.00064	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CYP19A1—obesity	0.000209	0.00064	CbGpPWpGaD
Ibandronate—Dizziness—Topiramate—obesity	0.000206	0.000397	CcSEcCtD
Ibandronate—Vomiting—Topiramate—obesity	0.000198	0.000382	CcSEcCtD
Ibandronate—Rash—Topiramate—obesity	0.000197	0.000378	CcSEcCtD
Ibandronate—Dermatitis—Topiramate—obesity	0.000197	0.000378	CcSEcCtD
Ibandronate—Headache—Topiramate—obesity	0.000196	0.000376	CcSEcCtD
Ibandronate—FDPS—Metabolism—COMT—obesity	0.000194	0.000595	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GNB3—obesity	0.000192	0.000587	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPARGC1A—obesity	0.000192	0.000587	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—HMOX1—obesity	0.000191	0.000584	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GNAS—obesity	0.000187	0.000571	CbGpPWpGaD
Ibandronate—Nausea—Topiramate—obesity	0.000185	0.000356	CcSEcCtD
Ibandronate—FDPS—Metabolism—APOB—obesity	0.000183	0.000559	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—LPL—obesity	0.000174	0.000534	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—GPX1—obesity	0.00017	0.000521	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CD36—obesity	0.000166	0.000507	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—MTHFR—obesity	0.000157	0.000481	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPARA—obesity	0.000154	0.000472	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AGT—obesity	0.000149	0.000457	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—APOE—obesity	0.000146	0.000448	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—CAV1—obesity	0.000145	0.000444	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—APOA1—obesity	0.000145	0.000443	CbGpPWpGaD
Ibandronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—obesity	0.000138	0.000424	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PIK3CG—obesity	0.000132	0.000404	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PPARG—obesity	0.000127	0.00039	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—POMC—obesity	0.000126	0.000385	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—INS—obesity	0.000125	0.000382	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PIK3CD—obesity	0.000116	0.000355	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—ALB—obesity	0.000115	0.000351	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—NOS3—obesity	0.00011	0.000335	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PIK3R1—obesity	0.00011	0.000335	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PIK3CB—obesity	0.000101	0.00031	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PTGS2—obesity	0.0001	0.000307	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—PIK3CA—obesity	6.16e-05	0.000189	CbGpPWpGaD
Ibandronate—FDPS—Metabolism—AKT1—obesity	5.04e-05	0.000154	CbGpPWpGaD
